The Effects of Renin–angiotensin System Inhibition on Regression of Encapsulating Peritoneal Sclerosis

Abstract

We suggest that RAS blockade either with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers may be a more effective option than resting in the management of EPS.